we're primarily paying for early stage basic science, which is the desired purpose of public funding. The huge investments in biotech and pharma (>$50M to bring

we're primarily paying for early stage basic science, which is the desired purpose of public funding. The huge investments in biotech and pharma (>$50M to bring a drug through clinical trials) are privately funded